¼¼°èÀÇ ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå : ¿¹Ãø(2025-2030³â)
Global Immunosuppressant Drugs Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1627626
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,715,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,583,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ¸é¿ª¾ïÁ¦Á¦ ½ÃÀå ±Ô¸ð´Â ¿¬Æò±Õ 12.42% ¼ºÀåÇÏ¿© 2025³â 427¾ï 2,100¸¸ ´Þ·¯¿¡¼­ 2030³â 767¾ï 1,900¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸é¿ª¾ïÁ¦Á¦´Â ÇǺÎÁúȯ, ´Ù¹ß¼º °æÈ­Áõ, ·ù¸¶Æ¼½º °üÀý¿°°ú °°Àº ÀÚ°¡¸é¿ªÁúȯ °ü¸®¿¡ ÀÓ»óÀûÀ¸·Î À¯¿ëÇÕ´Ï´Ù. ÇװźιÝÀÀÁ¦¶ó°íµµ ¾Ë·ÁÁø ÀÌ ¾àµéÀº ÀÌ½ÄµÈ Àå±â°¡ °ÅºÎ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â °ÍÀ» ¹æÁöÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µé, ƯÈ÷ Àå±â À̽ÄÀÌ ÇÊ¿äÇÑ »ç¶÷µéÀ» Áö¿øÇØ¾ß ÇÒ Çʿ伺°ú ÀÌ½Ä °úÁ¤À» °­È­ÇÏ´Â ±â¼ú ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» Å©°Ô Áõ°¡½Ãų °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

2023³â 9¿ù ¼¼°èº¸°Ç±â±¸(WHO) º¸°í¼­¿¡ µû¸£¸é, ºñ°¨¿°¼º Áúȯ(NCDs)À¸·Î ÀÎÇØ ¿¬°£ ¾à 4,100¸¸ ¸íÀÌ »ç¸ÁÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Àü ¼¼°è Àüü »ç¸ÁÀÚÀÇ ¾à 74%¿¡ ÇØ´çÇÕ´Ï´Ù. È£Èí±â, ¾Ï, ½ÅÀå, ½ÉÇ÷°üÁúȯ µîÀÌ Æ÷ÇԵ˴ϴÙ. ¸é¿ª¾ïÁ¦Á¦ °³¹ß ¹× Àå±â À̽ÄÀÇ ¹ßÀüÀ¸·Î À̵é ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÌ °¨¼ÒÇϸ鼭 ½ÃÀå È®´ë°¡ ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀÇ ÃËÁø¿äÀÎ

±Þ¼º ¹éÇ÷º´, ³­Ä¡¼º ºóÇ÷, °ñ´Ù°øÁõÀ¸·Î ÀÎÇØ Áٱ⼼Æ÷ À̽ÄÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÅÀå À̽ÄÀÇ ¿øÀÎÀÌ µÇ´Â ¸¸¼º ½ÅÀå Áúȯµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ Àå±â À̽Ŀ¡ ´ëÇÑ ºÎ´ãÀº ¸é¿ª¾ïÁ¦Á¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½ÃÄÑ ¼¼°è ½ÃÀå¿¡ ´õ ¸¹Àº ±â¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇèÀÇ È®´ë, M&AÀÇ Áõ°¡, ½Å¾à°³¹ßÀ» Áö¿øÇÏ´Â CDMO¿Í CROÀÇ ±Þ°ÝÇÑ ¼ºÀåµµ ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀÇ Áö¸®Àû Àü¸Á

±â¼úÀÇ ¹ßÀü°ú ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ Á¸Àç°¡ ÀÌ Áö¿ª ½ÃÀå °³Ã´À» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹, ij³ª´Ù µî¿¡¼­´Â Àå±â ÀÌ½Ä ¹× °ü·Ã ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¸é¿ª¾ïÁ¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁ® ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àå±â ±âÁõ¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ´õ ¸¹Àº ÀÌ½Ä ¼ö¼úÀÇ ¹®ÀÌ ¿­¸®°í ÀÖÀ¸¸ç, ÀÌ´Â ÇâÈÄ 5³â°£ ¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹Ì±¹¿¡¼­´Â ¼ºÀÎÀÇ 90%°¡ Àå±â ±âÁõÀ» ÁöÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ÀÚ°¡¸é¿ªÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿¬±¸ °³¹ß ºñ¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸é¿ª¾ïÁ¦Á¦ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¸¦ ±¸ÀÔÇØ¾ß ÇÏ´Â ÀÌÀ¯

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÀÔ Àü·«, Áö¸®Àû È®Àå, ÀÚº» ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

Á¦5Àå ¸é¿ª¾ïÁ¦Á¦ ¼¼°è ½ÃÀå : ¾à¹° Á¾·ùº°

Á¦6Àå ¸é¿ª¾ïÁ¦Á¦ ¼¼°è ½ÃÀå : ¿ëµµº°

Á¦7Àå ¸é¿ª¾ïÁ¦Á¦ ¼¼°è ½ÃÀå : À¯Åë ä³Îº°

Á¦8Àå ¸é¿ª¾ïÁ¦Á¦ ¼¼°è ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global Immunosuppressant Drugs market is expected to grow at a CAGR of 12.42%, reaching a market size of US$76.719 billion in 2030 from US$42.721 billion in 2025.

Immunosuppressive drugs find their clinical utility in managing autoimmune diseases such as skin disorders, multiple sclerosis, and rheumatoid arthritis. These medications, which are also known as anti-rejection medications, prevent our body from rejecting transplanted organs. The need to support populations with chronic ailments, particularly those requiring organ transplants and technological advancements that enhance the transplant process, would significantly increase market growth.

According to the World Health Organization report in September 2023, about 41 million die per year from noncommunicable diseases (NCDs), which equals about 74% of all deaths in the world. It would cover respiratory, cancer, kidney, cardiovascular diseases, etc. Improving immunosuppressive medications and the development of organ transplantation would hence reduce some of the mortalities caused by these diseases and boost market expansion.

Global Immunosuppressant Drugs Market Drivers

Stem cell transplant requirements are rising for acute leukemia, refractory anemia, and osteopetrosis, while there is an increase in chronic renal diseases that cause kidney transplants. The organ transplant burden has thus led to a colossal rise in the demand for immunosuppressants and has further contributed to the global market. Increasing clinical trials, growing mergers and acquisitions, and the fast-growing CDMOs and CROs supporting drug discovery and development are additional factors fostering market expansion.

Global Immunosuppressant Drugs Market Geographical Outlook

Technological advancements and the presence of significant market participants aid the development of this regional market. In nations like the US and Canada, rising demand for organ transplants and related procedures increases demand for immunosuppressive medications, propelling market expansion. Growing public awareness of organ donation is also opening the door for more transplant procedures, which will accelerate the immunosuppressive medication market's growth over the next five years. In the United States, 90% of adults favor organ donation. The market for immunosuppressive medications is expanding due to the region's increasing prevalence of autoimmune disease and R&D spending.

Reasons for buying this report:-

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

The global Immunosuppressant Drugs market is segmented and analyzed as follows:

By Drug Class

By Application

By Distribution Channel

By Geography

TABLE OF CONTENTS

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET BY DRUG CLASS

6. GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET BY APPLICATION

7. GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET BY DISTRIBUTION CHANNEL

8. GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â